ATC Group: A10BF Alpha glucosidase inhibitors

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A10BF in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A10 Drugs used in diabetes
3 A10B Blood glucose lowering drugs, excl. insulins
4 A10BF Alpha glucosidase inhibitors

Group A10BF contents

Code Title
A10BF01 Acarbose
A10BF02 Miglitol
A10BF03 Voglibose

Active ingredients in A10BF

Active Ingredient Description

Acarbose is an alpha-glucosidase inhibitors, used in the treatment of diabetes. Inhibitors of a-glucosidase retard the breakdown of carbohydrates in the food and reduce the increase in blood glucose levels, which occurs after each meal.


Miglitol is a reversible inhibitor of intestinal alpha-glucosidases. Under the influence of miglitol, the digestion of complex carbohydrates into absorbable monosaccharides in the small intestine is dosedependently delayed. Administration of miglitol thus leads to reduced postprandial hyperglycaemia and a smoothing effect on fluctuations in the daily blood glucose profile.


Related product monographs

Title Information Source Document Type  
GLUCOBAY 50mg Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC